Policy & Regulation
25 July 2025 - Commercial-stage biotechnology company Krystal Biotech Inc (NASDAQ:KRYS) announced on Friday that Japan's Ministry of Health, Labour and Welfare has approved VYJUVEK for the treatm...
25 July 2025 - Biopharmaceutical company Gilead Sciences Inc (Nasdaq:GILD) announced on Friday that it has received a positive opinion from the Committee for Medicinal Products for Human Use of the Eu...
25 July 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Friday that it has received European Commission approval for Sarclisa in combination with bortezomib...
25 July 2025 - GNT Pharma, a late-stage biopharmaceutical company with operations in Seoul and New York, announced on Thursday that its IND application to commence a Phase 3 clinical trial of its lead...
25 July 2025 - Altesa Biosciences, a US-based clinical-stage pharmaceutical company focused on preventing and treating the leading cause of COPD and asthma exacerbations, announced on Thursday that it...
24 July 2025 -

Alexion, AstraZeneca Rare Disease, the rare disease business unit of British-Swedish biopharmaceutical company AstraZeneca PLC (ST...